Cosopt and Ergocalciferol drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Cosopt and Ergocalciferol. Common interactions include hyperthermia among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people who take Cosopt and Ergocalciferol have. It is created by eHealthMe based on reports of 38 people who take Cosopt and Ergocalciferol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
38 people who take Cosopt and Ergocalciferol together, and have interactions are studied.
What is Cosopt?
Cosopt has active ingredients of dorzolamide hydrochloride; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 8,368 Cosopt users for its effectiveness, alternative drugs and more.
What is Ergocalciferol?
Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 23,359 Ergocalciferol users for its effectiveness, alternative drugs and more.
Number of Cosopt and Ergocalciferol reports submitted per year:
Common Cosopt and Ergocalciferol drug interactions by gender *:
- Hypoaesthesia oral
- Influenza like illness
- Intraocular pressure increased
- Loss of consciousness
- Macular degeneration
- Metastases to bone
- Metastases to liver
- Chronic kidney disease
- Renal failure
- Cardiorenal syndrome
- Implant site infection
Common Cosopt and Ergocalciferol drug interactions by age *:
- Diarrhoea haemorrhagic
- C-reactive protein increased
- Colitis microscopic
- Drug hypersensitivity
- Drug ineffective
- Drug intolerance
- Hepatic enzyme increased
- Abdominal distension
- Amaurosis fugax
- Atrophic vulvovaginitis
- Back disorder
- Benign neoplasm of adrenal gland
- Bone disorder
- Colitis microscopic
- Limb discomfort
- Skin reaction
- Thyroid disorder
Common conditions people have *:
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 18 people, 47.37%
- Constipation: 8 people, 21.05%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 15.79%
- Pain: 6 people, 15.79%
- Nausea (feeling of having an urge to vomit): 6 people, 15.79%
- Osteoporosis (bones weak and more likely to break): 5 people, 13.16%
- Parkinson's Disease: 2 people, 5.26%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 5.26%
- Muscle Spasms (muscle contraction): 2 people, 5.26%
- Insomnia (sleeplessness): 2 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Cosopt and Ergocalciferol?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Cosopt and Ergocalciferol:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Cosopt interactions:
Browse all interactions between Cosopt and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Ergocalciferol interactions:
Browse all interactions between Ergocalciferol and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on dorzolamide hydrochloride; timolol maleate and ergocalciferol (the active ingredients of Cosopt and Ergocalciferol, respectively), and Cosopt and Ergocalciferol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cosopt and Ergocalciferol.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Feldene and Malignant Melanoma - 8 seconds ago
- Folic Acid and Foot Fracture - 9 seconds ago
- Folic Acid and Aortic Valve Incompetence - 16 seconds ago
- Pravastatin Sodium and Cardiac Disorder - 26 seconds ago
- Potiga and Constipation - 41 seconds ago
- Tazorac and Back Pain Aggravated - 55 seconds ago
- Coronary Heart Disease and Dry Mouth - a minute ago
- Folic Acid and Injection Site Haematoma - a minute ago
- Metopirone and Death - a minute ago
- Constipation in Lamisil, how severe and when it was recovered? - a minute ago